# Mylan Technologies, Inc. – FDA Inspection, Sep 14, 2017

Source: https://www.keypedia.com/records/fda_inspections/mylan-technologies-inc/1626456b-8b63-4491-a40b-496bc50eb84d
Source feed: FDA_Inspections

> FDA inspection 1026374 of Mylan Technologies, Inc., September 14, 2017. Classification: Official Action Indicated (OAI). 2 citations under 21 CFR parts 211 and 820. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1026374
- Company Name: Mylan Technologies, Inc.
- Inspection Date: 2017-09-14
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New England District Office
- Citation Count: 2

## Related Documents

- FDA Inspection 1285894 - 2025-10-21
- FDA Inspection 1226467 - 2023-12-18
- FDA Inspection 1133997 - 2020-11-20
- FDA Inspection 1065833 - 2018-08-15
- FDA Inspection 970691 - 2016-04-13

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/james-norman/2e917a36-505a-44ed-b4e3-3dc0ef90a1f0)
- [FDA Associated Person](https://www.keypedia.com/people/jonathan-g-matrisciano/17e5bce2-75a6-4182-925d-b94b42763dd2)
- [Company Rep](https://www.keypedia.com/people/youmin-wang/a61763d9-5354-4e2f-9909-d2bacdd5c34d)

Company: https://www.keypedia.com/companies/mylan-technologies-inc/130d5987-f109-4e1e-bc68-d11396d48e70

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144